trial · primary record
Normal Saline (Placebo)
Malaria Falciparum
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 42 |
| Primary completion | 2027-12-30 |
| Primary endpoint | Safety and tolerability of administration of PfSPZ-LARC2 Vaccine, with special attention to the adequacy of attenuation, in the intention-to-treat (ITT) population: infection |
| Registry ID | NCT06862453 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:40.175Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06862453
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.